259 related articles for article (PubMed ID: 16301679)
61. A fiber-modified adenovirus co-expressing HSV-TK and Coli.NTR enhances antitumor activities in breast cancer cells.
Zhan Y; Yu B; Wang Z; Zhang Y; Zhang HH; Wu H; Feng X; Geng RS; Kong W; Yu XH
Int J Clin Exp Pathol; 2014; 7(6):2850-60. PubMed ID: 25031704
[TBL] [Abstract][Full Text] [Related]
62. Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.
Bramson JL; Grinshtein N; Meulenbroek RA; Lunde J; Kottachchi D; Lorimer IA; Jasmin BJ; Parks RJ
Hum Gene Ther; 2004 Feb; 15(2):179-88. PubMed ID: 14975190
[TBL] [Abstract][Full Text] [Related]
63. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
Wu H; Han T; Lam JT; Leath CA; Dmitriev I; Kashentseva E; Barnes MN; Alvarez RD; Curiel DT
Gene Ther; 2004 May; 11(10):874-8. PubMed ID: 14999229
[TBL] [Abstract][Full Text] [Related]
64. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy.
Han T; Tang Y; Ugai H; Perry LE; Siegal GP; Contreras JL; Wu H
Virol J; 2007 Oct; 4():103. PubMed ID: 17958897
[TBL] [Abstract][Full Text] [Related]
65. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
Mizuguchi H; Hayakawa T
Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
[TBL] [Abstract][Full Text] [Related]
66. Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5.
Coughlan L; Vallath S; Gros A; Giménez-Alejandre M; Van Rooijen N; Thomas GJ; Baker AH; Cascalló M; Alemany R; Hart IR
Hum Gene Ther; 2012 Sep; 23(9):960-79. PubMed ID: 22708837
[TBL] [Abstract][Full Text] [Related]
67. Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity.
Hong SS; Galaup A; Peytavi R; Chazal N; Boulanger P
Hum Gene Ther; 1999 Nov; 10(16):2577-86. PubMed ID: 10566886
[TBL] [Abstract][Full Text] [Related]
68. Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of alpha(v)beta3 integrins.
Harui A; Roth MD; Vira D; Sanghvi M; Mizuguchi H; Basak SK
J Leukoc Biol; 2006 Jun; 79(6):1271-8. PubMed ID: 16574766
[TBL] [Abstract][Full Text] [Related]
69. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
[TBL] [Abstract][Full Text] [Related]
70. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
71. Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism.
Martin K; Brie A; Saulnier P; Perricaudet M; Yeh P; Vigne E
Mol Ther; 2003 Sep; 8(3):485-94. PubMed ID: 12946322
[TBL] [Abstract][Full Text] [Related]
72. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.
Kim J; Smith T; Idamakanti N; Mulgrew K; Kaloss M; Kylefjord H; Ryan PC; Kaleko M; Stevenson SC
J Virol; 2002 Feb; 76(4):1892-903. PubMed ID: 11799184
[TBL] [Abstract][Full Text] [Related]
73. Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors.
Okada N; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Saito T; Fujita T; Yamamoto A; Hayakawa T; Mayumi T
Biochem Biophys Res Commun; 2001 Mar; 282(1):173-9. PubMed ID: 11263988
[TBL] [Abstract][Full Text] [Related]
74. Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys.
Goossens PH; Schouten GJ; 't Hart BA; Bout A; Brok HP; Kluin PM; Breedveld FC; Valerio D; Huizinga TW
Hum Gene Ther; 1999 May; 10(7):1139-49. PubMed ID: 10340546
[TBL] [Abstract][Full Text] [Related]
75. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
[TBL] [Abstract][Full Text] [Related]
76. Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.
Stoff-Khalili MA; Stoff A; Rivera AA; Mathis JM; Everts M; Wang M; Kawakami Y; Waehler R; Mathews QL; Yamamoto M; Rocconi RP; Siegal GP; Richter DF; Dall P; Zhu ZB; Curiel DT
Cancer Biol Ther; 2005 Nov; 4(11):1203-10. PubMed ID: 16177567
[TBL] [Abstract][Full Text] [Related]
77. Genetically modified adenovirus vector containing an RGD peptide in the HI loop of the fiber knob improves gene transfer to nonhuman primate isolated pancreatic islets.
Bilbao G; Contreras JL; Dmitriev I; Smyth CA; Jenkins S; Eckhoff D; Thomas F; Thomas J; Curiel DT
Am J Transplant; 2002 Mar; 2(3):237-43. PubMed ID: 12096786
[TBL] [Abstract][Full Text] [Related]
78. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
[TBL] [Abstract][Full Text] [Related]
79. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype.
Boissier MC; Lemeiter D; Clavel C; Valvason C; Laroche L; Begue T; Bessis N
Hum Gene Ther; 2007 Jun; 18(6):525-35. PubMed ID: 17532727
[TBL] [Abstract][Full Text] [Related]
80. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
